These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10325505)
1. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Bosland MC Eur Urol; 1999; 35(5-6):459-63. PubMed ID: 10325505 [TBL] [Abstract][Full Text] [Related]
2. Animal models for the study of prostate carcinogenesis. Bosland MC J Cell Biochem Suppl; 1992; 16H():89-98. PubMed ID: 1289679 [TBL] [Abstract][Full Text] [Related]
3. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of zinc on N-methyl-N-nitrosourea and testosterone-induced prostatic intraepithelial neoplasia in the dorsolateral prostate of Sprague Dawley rats. Banudevi S; Elumalai P; Sharmila G; Arunkumar R; Senthilkumar K; Arunakaran J Exp Biol Med (Maywood); 2011 Sep; 236(9):1012-21. PubMed ID: 21865407 [TBL] [Abstract][Full Text] [Related]
6. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate. Bosland MC; Prinsen MK; Dirksen TJ; Spit BJ Cancer Res; 1990 Feb; 50(3):700-9. PubMed ID: 2105161 [TBL] [Abstract][Full Text] [Related]
7. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Bosland MC; Prinsen MK Cancer Res; 1990 Feb; 50(3):691-9. PubMed ID: 2137026 [TBL] [Abstract][Full Text] [Related]
8. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats. Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279 [TBL] [Abstract][Full Text] [Related]
9. Multistage prostate carcinogenesis: the role of hormones. Bosland MC; Dreef-Van Der Meulen HC; Sukumar S; Ofner P; Leav I; Han X; Liehr JG Princess Takamatsu Symp; 1991; 22():109-23. PubMed ID: 1844235 [TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. McCormick DL; Rao KV; Steele VE; Lubet RA; Kelloff GJ; Bosland MC Cancer Res; 1999 Feb; 59(3):521-4. PubMed ID: 9973192 [TBL] [Abstract][Full Text] [Related]
11. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. McCormick DL; Rao KV Eur Urol; 1999; 35(5-6):464-7. PubMed ID: 10325506 [TBL] [Abstract][Full Text] [Related]
13. Effects of perinatal exposure to bisphenol A on induction of prostate cancer in Sprague Dawley rats by MNU and testosterone. Bosland MC; Schlicht MJ; Acevedo N; Soto AM; Prins G Toxicology; 2023 Jan; 484():153394. PubMed ID: 36521576 [TBL] [Abstract][Full Text] [Related]
14. 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats. Christov KT; Moon RC; Lantvit DD; Boone CW; Steele VE; Lubet RA; Kelloff GJ; Pezzuto JM Cancer Res; 2002 Sep; 62(18):5178-82. PubMed ID: 12234981 [TBL] [Abstract][Full Text] [Related]
15. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone. Tamano S; Rehm S; Waalkes MP; Ward JM Vet Pathol; 1996 Sep; 33(5):557-67. PubMed ID: 8885183 [TBL] [Abstract][Full Text] [Related]
16. The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis. Bosland MC; Schlicht MJ; Horton L; McCormick DL Toxicol Pathol; 2022 Jun; 50(4):478-496. PubMed ID: 35588266 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Rao KV; Johnson WD; Bosland MC; Lubet RA; Steele VE; Kelloff GJ; McCormick DL Cancer Res; 1999 Jul; 59(13):3084-9. PubMed ID: 10397249 [TBL] [Abstract][Full Text] [Related]
18. Multiple pathways of prostate carcinogenesis analyzed by using cultured cells isolated from rats treated with N-methyl-N-nitrosourea and testosterone. Condon MS; Kaplan LA; Crivello JF; Horton L; Bosland MC Mol Carcinog; 1999 Jul; 25(3):179-86. PubMed ID: 10411144 [TBL] [Abstract][Full Text] [Related]
20. [Influence of sodium selenite on carcinogenesis of the prostate and other organs induced by methylnitrosourea and testosterone in rats]. Bespalov VG; Panchenko AV; Murazov IaG; Chepik OF Vopr Onkol; 2011; 57(4):486-92. PubMed ID: 22191239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]